Cutting edge: Critical role for CD5 in experimental autoimmune encephalomyelitis: Inhibition of engagement reverses disease in mice

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 2928-2932

  Axtell, Robert C ^a   Webb, Matthew S ^b   Barnum, Scott R ^b   Raman, Chander ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[35-55]; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 4344655359     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.2928     Document Type: Article

References (21)

1. Chang, T. T., C. Jabs, R. A. Sobel, V. K. Kuchroo, and A. H. Sharpe. 1999. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J. Exp. Med. 190:733.
2. Chang, T. T., R. A. Sobel, T. Wei, R. M. Ransohoff, V. K. Kuchroo, and A. H. Sharpe. 2003. Recovery from EAE is associated with decreased survival of encephalitogenic T cells in the CNS of B7-1/B7-2-deficient mice. Eur. J. Immunol. 33:2022.
3. Chang, J. T., B. M. Segal, and E. M. Shevach. 2000. Role of costimulation in the induction of the IL-12/IL-12 receptor pathway and the development of autoimmunity. J. Immunol. 164:100.
4. Perrin, P. J., C. H. June, J. H. Maldonado, R. B. Ratts, and M. K. Racke. 1999, Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 163:1704.
5. Racke, M. K., D. E. Scott, L. Quigley, G. S. Gray, R. Abe, C. H. June, and P. J. Perrin. 1995. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96:2195.
6. Salama, A. D., T. Chimis, J. Imitola, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198:71.
7. Lozano, F., M. Simarro, J. Calvo, J. M. Vila, O. Padilla, M. A. Bowen, and K. S. Campbell. 2000. CD5 signal transduction: positive or negative modulation of antigen receptor signaling. Crit. Rev. Immunol. 20:347.
8. Tarakhovsky, A., S. B. Kanner, J. Hombach, J. A. Ledbetter, W. Muller, N. Killeen, and K. Rajewsky. 1995. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 269:535.
9. Pena-Rossi, C., L. A. Zuckerman, J. Strong, J. Kwan, W. Ferris, S. Chan, A. Tarakhovsky, A. D. Beyers, and N. Killeen. 1999. Negative regulation of CD4 lineage development and responses by CD5. J. Immunol. 163:6494.
10. Bhandoola, A., R. Bosselut, Q. Yu, M. L. Cowan, L. Feigenbaum, P. E. Love, and A. Singer. 2002. CD5-mediated inhibition of TCR signaling during intrathymic selection and development does not require the CD5 extracellular domain. Eur. J. Immunol. 32:1811.
11. Azzam, H. S., A. Grinberg, K. Lui, H. Shen, E. W. Shores, and P. E. Love. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188:2301.
12. Smith, K., B. Seddon, M. A. Purbhoo, R. Zamoyska, A. G. Fisher, and M. Merkenschlager. 2001. Sensory adaptation in naive peripheral CD4 T cells. J. Exp. Med. 194:1253.
13. Kassiotis, G., R. Zamoyska, and B. Stockinger. 2003. Involvement of avidiry for major histocompatibility complex in homeostasis of naive and memory T cells. J. Exp. Med. 197:1007.
14. Szalai, A. J., S. Nataf, X. Z. Hu, and S. R. Barnum. 2002. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J. Immunol. 168:5792.
15. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J. L. Vayssiere, P. X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1661.
16. Zhang, H. G., T. Zhou, P. Yang, C. K. Edwards III, D. T. Curiel, and J. D. Mountz. 1998. Inhibition of tumor necrosis factor a decreases inflammation and prolongs adenovirus gene expression in lung and liver. Hum. Gene Ther. 9:1875.
17. Raman, C. 2002. CD5, an important regulator of lymphocyte selection and immune tolerance. Immunol. Res. 26:255.
18. Ahmed, K., D. A. Gerber, and C. Cochet. 2002. Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol 12:226
19. Raman, C., and R. P. Kimberly. 1998. Differential CD5-dependent regulation of CD5-associated CK2 activity in mature and immature T cells: implication on TCR/CD3-mediated activation. J. Immunol. 161:5817.
20. Mihara, M., I. Tan, Y. Chuzhin, B. Reddy, L. Budhai, A. Holzer, Y. Gu, and A. Davidson. 2000. CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus. J. Clin. Invest. 106:91.
21. Khoury, S. J., E. Akalin, A. Chandraker, L.A. Turka, P. S. Linsley, M. H. Sayegh, and W. W. Hancock. 1995. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J. Immunol. 155:4521.